Thank you very much for the introduction.
I'm Isra Levy. I'm the vice-president of medical affairs and innovation at Canadian Blood Services, and there I work with our organ and tissue donation and transplantation team, supporting and coordinating Canada's provincial and territorial donation and transplantation organizations, programs, and clinicians in their critically important and life-saving work at the bedside.
I am pleased to be joined by my colleague Amber Appleby today. Amber is the acting director of donation and transplantation at Canadian Blood Services, and will be available for questions.
It's also a privilege to appear together with some of our partners, not only Trillium Gift of Life and B.C. Transplant, but also later this week, I'm aware that you'll be hearing from another major partner, the Canadian National Transplant Research Program. I think this exemplifies the degree to which we see the collaborative nature of this exercise as being the only way to success on the way forward.
It's trite to say, and I know you are already aware of it, but for every patient in Canada who does receive an organ transplant, which is obviously life-saving, there are two more on the waiting list. Every year we know that people die while waiting, in fact, probably more than one every two days. At least 200 Canadians died while waiting for a suitable transplant opportunity last year.
There is a lot to do, but there's real cause for some reflection on progress to date. Canada's deceased donation rate, which is the organ donation numbers by deceased donors, last year was 21.8 donors per million population, which is a really marked improvement when you compare that with the last five and 10-year periods, but it is still less than a half the rate of some of the highest-performing countries around the world.
Our living donation rate, on the other hand, compares quite favourable internationally, but there we are seeing challenges, and we've seen declines year over year in the last few years when you look across the country.
In recognition of some of the deficits in the system, going way back now, some changes have been made by you and by your predecessors. In 2008, Canadian Blood Services was asked by federal, provincial, and territorial ministers of health to help strengthen the system across the country, particularly in helping jurisdictions support each other and increase access to transplant opportunities that may cross jurisdictional boundaries. An equity of access underpinning was very much at the forefront of the work when we got involved in it.
Of course, organ donation and transplantation are unique and highly specialized, interdependent areas of practice, and they're episodic and resource-intensive. The degree of clinical, provincial, interprovincial, and national co-operation that's required to facilitate the successes that I referred to are really quite significant. Certainly at CBS we're proud that we can be facilitatory and instrumental in supporting these activities.
The partnership that we enjoy with provincial and national stakeholders is informed by successful international models, and together with our provincial and clinical partners, we've developed a plan to improve system performance. That plan has been implemented, at least in part. We've been helped by federal, provincial, and territorial funders for support for different components of the plan, and it has underpinned those successes. As I've mentioned, we've shown a sustained improvement in deceased organ donation, which is a significant and important achievement for the country.
Leanne mentioned that we've also had significant successes in living donation in the coordination at the national level, through what we call the kidney paired donation program.
I think it is worth just reflecting that the partnership, which was launched in 2008, has created more than 575 transplant opportunities for patients with incompatible but living donors. When one thinks about it, that's an average of more than one transplant every week for each week in the last 10 years, which has been a result of this co-operative program. Those are transplants that would not have occurred without the program that connects the incompatible pairs from across the country to find suitable donor exchanges.
Of course, another milestone that I know many of you helped us celebrate last week was a milestone of national collaboration. It was the achievement of the 1,000th kidney transplant facilitated by the interprovincial organ-sharing work that we do.
We know that knowledge of performance drivers, leadership, and coordination at all levels of the system have been and will continue to be basic success ingredients for continued improvement of the national system, but of course you're here because you know that much remains to be done. Certainly when I reflected on what we might bring to you that would be helpful, I thought it was important to emphasize the inescapable and regrettable fact that it does matter where one lives in this country in terms of the probability of being able to be either a donor or a recipient.
There's no question that performance varies across jurisdictional and even institutional programming. That is something we can collectively put our minds to, I think. The role and scope of activities across jurisdictions with donation programs working with hospitals facilitating the donation process does vary. We see some programs responsible for deceased donation only. We see others include aspects of living donation, transplant services, etc. Some will include tissue donation. Others don't. Some have no deceased donation program at all. Others have no living donation program.
The challenges of this interjurisdictional inconsistency are many. It's important, of course, because we must remember that only a small percentage—and it's probably less than 2%—of deaths in Canada occur in a way that can actually lead to the individual becoming a donor. So the rarity of the potential donor is such that it really behooves us not to miss the opportunity, when we have the opportunity, to use that donation of an organ or set of organs.
I've mentioned the living donation programs that have also been added to the deceased donation programs in order to increase the frequency, and we've certainly seen that provinces that invest in the infrastructure for deceased donations and that also invest in increasing their living donation rates, see the returns in increased transplants for their patients.
I think one of the things we can collectively do is seek to make the opportunities available for those who want to donate, ensure the system can assess potential living donors as well as promote deceased donation, and allow them to donate in reasonable timelines.
We at CBS, with the partnerships, really understand that the degree to which donation and transplantation services are organized and operated in each province is something that we can ensure gets shared. It is foundational to assessing the impact on access to care and improving performance. Doing that from a national focus, I think, requires that jurisdiction-specific challenges be understood and addressed, and that jurisdictions and institutions and programs be supported to ensure that when donation opportunities arise they are not lost.
In future, then, I think what we would offer is that Canada's performance in donation and transplantation should be measured based on inputs, certainly, such as the ones I've mentioned—maximizing living and deceased donors—but also on outcomes.
We should be starting to turn our attention to facilitating the greatest number of transplants possible for patients who need them, but also to do this as quickly as possible and ensure the best possible clinical outcome from the best possible match to improve the quality of life for the long term.
Therefore, the underpinning research of our partners in CNTRP, the research part of the this partnership, is all the more important. The recipe for system improvement can continually be looked at and improved upon, but we know that when key ingredients are implemented, marked improvement happens.
Based on our experiences as a coordinating body for these donations and transplants in Canada, we would recommend that national priorities focus on strategies to advance interprovincial organ sharing, that we seek to advance living and deceased donations by assisting jurisdictions in their implementation challenges. Together, these elements will enhance system performance. There's a role in national system performance measurement. That measurement will help to drive increased performance and quality and promote an accountable system.
Opportunities for federal support I believe include facilitating referral of potential donors, education and awareness, and promoting optimal and consistent practices across jurisdictions.
Focusing on those measures to improve consistency will ensure all stakeholders are invested, and that donors and organs are not lost to avoidable factors, which results in harm or even death for a transplant candidate who then does not get the successful transplant. A national approach to leading practice development, to public and professional education, to system performance measurement and improvement, and to coordination of advanced interprovincial organ sharing, we think, would be cost-effective, is cost-effective, and will continue to deliver ever-better outcomes for Canadians.
I've probably gone over the 10 minutes. Sorry about that. I'll conclude by saying that in the last 10 years we have seen considerable progress in advancing the performance of the organ and tissue donation and transplantation system in Canada. The national collaborative work, which we've been privileged and proud to facilitate, has helped to increase those rates. It's helped therefore to save and improve lives, and it's led to avoided costs for the health-care system.
We are very encouraged. We know that Health Canada officials have embarked on collaborative efforts with provincial and territorial officials to identify and advance critical next steps, to further define roles and responsibilities, and to examine what additional opportunities applied nationally might have the most significant impact. We're grateful for that. We're grateful for your ongoing interest and support.
Together, we can save lives.